Worsening of asthma control after COVID-19
Open Access
- 14 September 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 882665
Abstract
Background: SARS-CoV-2 enters lung cells via angiotensin-converting enzyme 2 (ACE2) receptor. Several studies suggest that interleukin-13, an important cytokine involved in T2 inflammation, reduces ACE2 expression, and therefore, asthma would not be a significant risk factor for the development of severe COVID-19. However, several asthma-related risk factors should be valued during the concurrent occurrence of asthma and COVID-19. The purpose of this study was to compare the evolution of asthma in patients who had COVID-19 with those who did not have the disease.Methods: This was an observational and retrospective study involving asthmatic patients followed up at a tertiary center. Patients were assessed for severity of asthma, atopy, comorbidities, and COVID-19. Worsening of asthma was considered when, during the period of Sept 2020 to Oct 2021, patients referred an increasing of asthma symptoms and a need to increment their maintenance therapy.Results: This study included 208 asthmatic patients, the mean age was 52.75 years, 79.81% were atopic asthmatics, and 59 (28.37%) had laboratory-confirmed coronavirus disease. Of all patients infected with the SARS-CoV-2, eleven (18.64%) needed hospitalization and required oxygen supply with an O2 mask. Comparing the worsening of asthma between patients who had COVID-19 and those who had not the disease, there was a statistically significant difference, 33.90 vs. 11.41%, respectively (p < 0.001). There was no statistical significance regarding asthma comorbidities.Conclusion: This study assessed a group of asthmatic patients that had COVID-19, and that although the respiratory symptoms related to COVID-19 were mild to moderate, a subgroup of these asthmatic patients evolved with a chronic worsening of their asthma requiring an increment in asthma medication to control the disease.Keywords
This publication has 29 references indexed in Scilit:
- Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?The Lancet Respiratory Medicine, 2020
- Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illnessJournal of Allergy and Clinical Immunology, 2017
- Biomarker Profiles in Asthma With High vs Low Airway Reversibility and Poor Disease ControlChest, 2015
- Assessment of Environmental Cockroach Allergen ExposureCurrent Allergy and Asthma Reports, 2012
- The microbiology of asthmaNature Reviews Microbiology, 2012
- Novos valores de referência para espirometria forçada em brasileiros adultos de raça brancaJornal Brasileiro de Pneumologia, 2007
- Interpretative strategies for lung function testsEuropean Respiratory Journal, 2005
- Standard skin prick testing and sensitization to inhalant allergens across Europe – a survey from the GA2LEN network*Allergy, 2005
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- Cockroach allergens and asthmaJournal of Allergy and Clinical Immunology, 2001